NCT00991614已完成不适用
Treatment of Duodenal or Gastric Outlet Obstruction and Duodenal Strictures Caused by Malignant Neoplasms With the EVOLUTION® Duodenal Stent
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 110
- 试验地点
- 6
- 主要终点
- Patency of the stent
研究概览
简要总结
The objective of this investigation is to compile clinical experience on the use of the Evolution® Duodenal Stent (Cook Ireland), a CE marked device intended for the palliative treatment of duodenal or gastric outlet obstruction and duodenal strictures caused by malignant neoplasms. It is not the goal to change the usual treatment practice of the investigator or the center, nor to collect information on uses outside the product's indications. Patients will be treated as per usual medical practices.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients for whom this device would be chosen in standard practice
排除标准
- •Patients for whom this device would not normally be chosen in standard practice
结局指标
主要结局
Patency of the stent
时间窗: 14 days
次要结局
- Procedural success, implant duration, symptom resolution(up to 6 months)
研究者
研究点 (6)
Loading locations...
相似试验
已完成
不适用
Treatment of Colonic Obstruction With Cook Evolution® Colonic Stent SystemColonic ObstructionColonic StrictureLarge Bowel ObstructionNCT01102283Cook Group Incorporated80
撤回
不适用
Duodenal Exclusion for the Treatment of Type 2 DiabetesDiabetesNCT00534547Medtronic - MITG
Unknown
不适用
Endoscopic Ultrasound-guided Versus Surgical Gastroenterostomy for Malignant Gastric Outlet ObstructionMalignant Gastric Outlet ObstructionNCT05564143National Taiwan University Hospital60
已完成
4 期
Duodenal Exclusion for the Treatment of T2DMDiabetesNCT00456352Medtronic - MITG37
终止
不适用
Domperidone for Relief of Gastrointestinal DisordersGERDChronic Idiopathic ConstipationNauseaEsophagitisVomitingGastroparesisDyspepsiaNCT00761254Carle Physician Group42